Alimera, PSivida Drop After Drug Fails to Win Approval

Alimera Sciences Inc. and PSivida Corp. dropped after the drugmakers failed to win U.S. approval for a way to treat a leading cause of vision loss in people with diabetes.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.